bioRxiv
Cure8 research brief
Why This Matters
This study suggests there are distinct molecular subtypes of perianal fistulizing Crohn’s disease, and some subtypes may be more likely to benefit from surgical repair while others have higher inflammatory burden and risk of ileostomy.
Who Should Pay Attention
Researchers studying IBD pathogenesis and biomarkers; colorectal surgeons and IBD clinicians managing perianal disease; patients with perianal fistulizing Crohn’s disease interested in research on personalized treatment.
Study Snapshot
Story typePress release
Evidence typePreprint
Study statusPreprint
Source depthJournal abstract
What To Know
This preprint reports that unsupervised analysis of RNA-seq and 16S data from paired fistula and rectal biopsies revealed three molecular clusters. One cluster showed a keratinization/psoriasis-like signature and reduced JAK–STAT signalling and was enriched in patients deemed more suitable for surgical repair.
Another cluster showed epithelial–mesenchymal transition (EMT), higher MRI inflammatory-mass scores, and a higher risk of later ileostomy. The study used longitudinal sampling and validated the keratinization signature in an independent RNA-seq dataset. Because this is a preprint, findings are preliminary and have not completed peer review.
Practical takeaway: The work suggests that molecular profiling of perianal fistula tissue could eventually help guide decisions about surgery versus other therapies, but it does not change clinical care now.
Keep In Mind
This is a bioRxiv preprint (not peer-reviewed). The findings are grounded in the paper's abstract and reported analyses; clinical implications are preliminary and would need validation in larger, prospective cohorts before changing practice.
Source Details
Review the original publication for the complete reporting, methods, and context.
Preprint
Evidence type derived from source or registry metadata.
PublicationbioRxiv
AuthorsAbdurahiman, S., Sabino, J., Verstockt, S. +17 more
Study typeNew results
Indexed viabioRxiv
Source typePreprint
PublishedJul 26, 2026, 12:00 AM
Content availableJournal abstract
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
Tissue transcriptional programs stratify Crohn's disease by therapeutic response and clinical ...
The study identifies colonic gene-expression programs that correlate with treatment failure, higher surgery rates, and perianal disease in Crohn’s — findings that could guide future prognostic tests and targeted...
Local and circulating cytotoxic CD4+ T cells are early markers of disease activity in pediatric Crohn's disease
If validated, a blood test for cytotoxic CD4+ T cells at diagnosis could help predict who is less likely to respond to anti‑TNF drugs, potentially allowing earlier selection of alternative therapies for some children...
Risk factors and fatigue in difficult-to-treat Crohn’s disease: A cross-sectional study of a Chinese cohort
Identifies features associated with the new international definition of difficult‑to‑treat Crohn’s disease and links DTT status to greater mental fatigue. Biomarker differences (IL‑5, IL‑10) may point to distinct immune...